Combating Drug-Resistant Mutants of Anaplastic Lymphoma Kinase with Potent and Selective Type-I<sup>1/2</sup> Inhibitors by Stabilizing Unique DFG-Shifted Loop Conformation

Peichen Pan(Pharmaceutical Biotechnology (Czechia)), Tingjun Hou(Zhejiang University)

ACS Central Science

November 3, 2017

10.1021/acscentsci.7b00419

Cited by 49

Related Papers

Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays

|Acta Pharmacologica Sinica|2021|20

Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays

|Unknown|2020|1